Greetings, folks!  It has been way too long since I've written a PT coverage and it's time for me to get back on the horse.  I see that despite my long-term absence, I still have at least one coverage residing on the "most popular" list...my AIS coverage, relating to self-injection products.  That stock's value has increased 45% since I wrote the coverage, but I'd imagine some of its popularity can be attributed to the amusing image I used to accompany it.

Seeing as I've had success in the past with certain types of coverage (small-cap tech & biotech stocks, Maryland-based companies, etc.), I'm going to toss out another piece of sharp advice on a company that makes injectables.  Granted, they also sell tablets, caplets, transdermal patches, and other delivery devices for generic and branded generic medicines, but my what caught my eye when researching this stock was the EpiPen.

Seems to me that about every third or fourth person I meet these days has experienced a severe allergic reaction at some point, and has either jammed an EpiPen into their own person or had some other person jam an EpiPen into their person.  I have personally jammed EpiPens into four people in my life, but I have yet to use one on myself.

This is one of those "seen it too often in real life for it not to be a winner" picks.  Get stabby with me, folks, and inject some life into your portfolio!